Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Crit Care Med. 2011 May;39(5):952–960. doi: 10.1097/CCM.0b013e31820a92c6

Table 4.

Incidence and associated mortality of diseases defined by laboratory abnormalities

Type of Pathology Laboratory Abnormality No. of ICU Stays With at Least One Valid Measurementa No. of ICU Stays With at Least One Episode of Abnormality Associated Mortality Rate (Positive Cases) Associated Mortality Rate (Negative Controls) Odds Ratio 95% CI
Metabolic acidosis Arterial pH <7.2 and HCO3 <18 12,894 785 53.1% 12.7% 7.8 6.7–9.0
Thrombocytopenia Platelet count <50,000 18,917 872 42.2% 9.8% 6.7 5.8–7.8
Renal insufficiency Creatinine ≥2 mg/dL 18,855 3523 25.8% 8.2% 3.9 3.5–4.3
Hypoglycemia Glucose <40 18,261 163 31.9% 11.6% 3.5 2.5–4.9
Hepatitis Bilirubin >4.0 OR AST > 500 OR ALT > 500 8364 1327 35.8% 14.7% 3.3 2.9–3.7
Leukocytosis White blood count >15,000 18,509 7079 18.6% 7.1% 3.0 2.7–3.2
Acute lung injury PaO2/FIO2 ≤300 mm Hg 10,476 6819 19.8% 12.5% 2.0 1.8–2.3
Anemia Hematocrit <25 19,046 4835 15.0% 10.0% 1.6 1.4–1.8
Myocardial infarction Troponin T >0.1 ng/dL or Troponin I >2.0 ng/dL 5022 2904 21.3% 18.9% 1.2 1.0–1.4

ICU, intensive care unit; CI, confidence interval; AST, aspartate aminotransferase; ALT, alanine transaminase.

a

Excludes hospitalizations with multiple ICU stays and the last 12 hrs of every patient record to avoid end-of-life physiology. Note that odds ratio applies only to ICU stays in which the diagnostic test was performed.